The "homemade" HIPEC machine - a cost-effective alternative in low-resource countries [0.03%]
“自制”的HIPEC机——低资源国家的一种低成本替代方案
Aditi Bhatt,Robin Prabhu,Kayomarz Sethna et al.
Aditi Bhatt et al.
Background: HIPEC using custom-made machines (CMM) remains unaffordable for many patients in low-income countries. We describe the assembly and use homemade HIPEC machine (HMM) as a cost-effective alternative. ...
Florian Struller,Frank-Jürgen Weinreich,Philipp Horvath et al.
Florian Struller et al.
The parietal peritoneum (PP) is innervated by somatic and visceral afferent nerves. PP receives sensitive branches from the lower intercostal nerves and from the upper lumbar nerves. Microscopically, a dense network of unmyelinated and myel...
Medical devices for treating peritoneal metastasis in low-income countries: is less more? [0.03%]
低收入国家治疗腹膜转移性癌症的医疗器械：少即是多？
Marc Pocard
Marc Pocard
Comparison of GATA-3, mammaglobin, GCDFP-15 expression in breast carcinoma in serous effusions: A cell-block micro-array study [0.03%]
GATA-3、乳腺球蛋白和GCDFP-15在胸水中乳头状导管癌细胞块微阵列中的表达比较研究
Mohamed I El Hag,Amani M Hag,Jennifer P Ha et al.
Mohamed I El Hag et al.
Background: GATA-3 is a potential marker for detection of metastatic breast carcinoma, reportedly more sensitive than mammaglobin (MAM) and GCDFP-15. We aim to compare the sensitivity of GATA-3, MAM and GCDFP-15 in determ...
Neutropenia and thrombocytopenia after cytoreductive surgery and heated intraperitoneal chemotherapy [0.03%]
减瘤手术和腹腔热灌注化疗后的中性粒细胞减少症和血小板减少症
Ben Finlay,Timothy Price,Peter Hewett
Ben Finlay
Background: Neutropenia and thrombocytopenia are well-recognised complications of systemic chemotherapy. In cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC), the interplay between surgical factors and...
Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [0.03%]
细胞减灭术和腹腔内热灌注化疗的非常规适应证
Francis Zheng Yi Yee,Grace Hwei Ching Tan,Claramae Shulyn Chia et al.
Francis Zheng Yi Yee et al.
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed treatment for selected patients with peritoneal metastases (PM) arising from appendiceal, colorectal, epithelial o...
Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) [0.03%]
压灌式腹腔化疗(PIPAC)的职业安全防护措施研究
Wouter Willaert,Paul Sessink,Wim Ceelen
Wouter Willaert
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has emerged as a novel method to treat extensive, small volume peritoneal metastases. The clinical use of chemotherapy containing aerosols represents a ...
Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study [0.03%]
评估一种新型祛痰溶液溶解假性黏液瘤腹膜腔粘液的疗效：体外和离体研究
Krishna Pillai,Javed Akhter,David L Morris
Krishna Pillai
Background: Pseudomyxoma peritonei (PMP) is difficult to treat. Intraperitoneal delivery of mucolytic solutions might potentially improve therapy, in addition to surgical cytoreduction and hyperthermic intraperitoneal che...
Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy [0.03%]
结肠癌PIPAC给药的化疗药代动力学实验评估：疗效有效性的首个证据
Clarisse Eveno,Aminata Haidara,Ibrahim Ali et al.
Clarisse Eveno et al.
Background: Pressurised intraperitoneal aerosol chemotherapy (PIPAC) is a novel technique of intraperitoneal chemotherapy devoted to unresectable peritoneal metastasis (PM). The first results obtained with PIPAC in precli...